On 28 June 2019, Oncopeptides announced the successful completion of a directed share issue of approximately SEK 727 million at a subscription price of SEK 145 per share.
The annual Extel survey for the European equities investment industry has just been released. DNB Markets was ranked second overall among the leading brokerage firms in the Nordics, retaining its position from last year.
Due to system upgrade, DNB Alpha might be unavailable this weekend.
Presentations from DNB's 12th annual Oil, Offshore & Shipping Conference are now available.
Equinor Energy Ventures, Nysnø Climate investments and existing shareholders (including Kongsberg Digital) invest NOK 150m in the Norwegian software company eSmart Systems.
On 24 January 2019, Oncopeptides announced the successful completion of a directed share issue of approximately SEK 546 million at a subscription price of SEK 115 per share.
The DNB Markets’ FICC Macro, FX and Commodity Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.